Personal information

Switzerland

Activities

Employment (4)

University Hospital of Basel: Basel, CH

2021-09 to present | Bioinformatician (Brain Tumor Immunotherapy)
Employment
Source: Self-asserted source
Sabrina Hogan (Schindler)

University Hospital of Zurich: Zurich, CH

2019-07 to present | Project Manager (Dermatology)
Employment
Source: Self-asserted source
Sabrina Hogan (Schindler)

University Hospital of Zurich: Zurich, CH

2015-11-09 to 2019-06 | PhD student (Dermatology)
Employment
Source: Self-asserted source
Sabrina Hogan (Schindler)

Nestlé Research Center: Lausanne, VD, CH

2012-02 to 2012-08 | Junior Research Assistant
Employment
Source: Self-asserted source
Sabrina Hogan (Schindler)

Education and qualifications (4)

University of Zurich: Zurich, CH

2015-11-09 to 2019-03-07 | PhD (Cancer Biology Program)
Qualification
Source: Self-asserted source
Sabrina Hogan (Schindler)

University of Reading: Reading, Berkshire, GB

2014-09-15 to 2015-09-15 | MRes in Biomedical Research (School of Biological Sciences)
Education
Source: Self-asserted source
Sabrina Hogan (Schindler)

Universite de Lausanne: Lausanne, VD, CH

2010-09-15 to 2012-09-15 | MSc in Medical biology (Faculté de biologie et de médecine)
Education
Source: Self-asserted source
Sabrina Hogan (Schindler)

Universite de Lausanne: Lausanne, VD, CH

2007-06-15 to 2010-06-15 | Bachelor of Science in Biology (Faculty of Biology and Medicine)
Education
Source: Self-asserted source
Sabrina Hogan (Schindler)

Professional activities (3)

GenoMEL: Essen, DE

2018 | Award for scientific excellence for oral presentation (GenoMEL scientific meeting 2018)
Distinction
Source: Self-asserted source
Sabrina Hogan (Schindler)

Society for Melanoma Research: Brisbane, AU

2017 | Travel Award
Distinction
Source: Self-asserted source
Sabrina Hogan (Schindler)

Search Results Web result with site links European Association of Dermato Oncology: Athens, GR

2017 | Best poster presentation
Distinction
Source: Self-asserted source
Sabrina Hogan (Schindler)

Funding (1)

MELGEN European Training Network (ETN)

2015 to 2019 | Grant
H2020 Marie Skłodowska-Curie Actions (Europe, CH)
Source: Self-asserted source
Sabrina Hogan (Schindler)

Works (19)

Multidimensional analysis of matched primary and recurrent glioblastoma identifies contributors to tumor recurrence influencing time to relapse.

Journal of neuropathology and experimental neurology
2024-10-18 | Journal article
Contributors: Shekarian T; Marie-Françoise Ritz; Hogan S; Martins TA; Schmassmann P; Gerber A; Roux J; Kaymak D; Durano C; Burger B et al.
Source: Self-asserted source
Sabrina Hogan (Schindler)

Proteomic Profiling of Advanced Melanoma Patients to Predict Therapeutic Response to Anti-PD-1 Therapy.

Clinical cancer research : an official journal of the American Association for Cancer Research
2024-01-01 | Journal article | Author
Contributors: Nina Zila; Ossia M. Eichhoff; Irene Steiner; Thomas Mohr; Andrea Bileck; Phil Cheng; Alexander Leitner; Ludovic Gillet; Tatjana Sajic; Sandra Goetze et al.
Source: Self-asserted source
Sabrina Hogan (Schindler)

Single-cell characterization of human GBM reveals regional differences in tumor-infiltrating leukocyte activation

eLife
2023-12-21 | Journal article | Author
Part of ISSN: 2050-084X
Contributors: Philip Schmassmann; Julien Roux; Steffen Dettling; Sabrina Hogan (Schindler); Tala Shekarian; Tomás A. Martins; Marie-Françoise Ritz; Sylvia Herter; Marina Bacac; Gregor Hutter
Source: Self-asserted source
Sabrina Hogan (Schindler)

Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma.

Science translational medicine
2023-07-19 | Journal article | Author
Contributors: Philip Schmassmann; Julien Roux; Alicia Buck; Nazanin Tatari; Sabrina Hogan (Schindler); Wang J; Rodrigues Mantuano N; Wieboldt R; Sohyon Lee; Berend Snijder et al.
Source: Self-asserted source
Sabrina Hogan (Schindler)

PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors.

Frontiers in oncology
2022-11-24 | Journal article
Contributors: Gabryś HS; Basler L; Simon Burgermeister; Hogan S; Ahmadsei M; Pavic M; Bogowicz M; Diem Vuong; Tanadini-Lang S; Förster R et al.
Source: Self-asserted source
Sabrina Hogan (Schindler)

Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study.

Nature communications
2022-11-09 | Journal article
Contributors: Manina Maja Etter; Tomás A. Martins; Laila Kulsvehagen; Elisabeth Pössnecker; Duchemin W; Hogan S; Sanabria-Diaz G; Jannis Müller; Chiappini A; Jonathan Rychen et al.
Source: Self-asserted source
Sabrina Hogan (Schindler)

Immunotherapy of glioblastoma explants induces interferon-γ responses and spatial immune cell rearrangements in tumor center, but not periphery.

Science advances
2022-07-01 | Journal article | Author
Contributors: Tala Shekarian; Carl Philipp Zinner; Ewelina M Bartoszek; Wandrille Duchemin; Anna Teresa Wachnowicz; Sabrina Hogan (Schindler); Manina Maja Etter; Flammer J; Paganetti C; Tomás A. Martins et al.
Source: Self-asserted source
Sabrina Hogan (Schindler)

Improved Survival Prediction by Combining Radiological Imaging and S-100B Levels Into a Multivariate Model in Metastatic Melanoma Patients Treated With Immune Checkpoint Inhibition.

Frontiers in oncology
2022-04-14 | Journal article
Contributors: Simon Burgermeister; Gabryś HS; Basler L; Hogan SA; Matea Pavic; Bogowicz M; Martínez Gómez JM; Diem Vuong; Stephanie Tanadini-Lang; Robert Foerster et al.
Source: Self-asserted source
Sabrina Hogan (Schindler)

Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism.

Nature cancer
2021-11 | Journal article
Contributors: García-Silva S; Benito-Martín A; Nogués L; Hernández-Barranco A; Mazariegos MS; Santos V; Hergueta-Redondo M; Ximénez-Embún P; Kataru RP; Lopez AA et al.
Source: Self-asserted source
Sabrina Hogan (Schindler) via Europe PubMed Central

Interleukin-6 blockade for prophylaxis and management of immune-related adverse events in cancer immunotherapy.

European journal of cancer (Oxford, England : 1990)
2021-09 | Journal article
Contributors: Dimitriou F; Hogan S; Menzies AM; Dummer R; Long GV
Source: Self-asserted source
Sabrina Hogan (Schindler) via Europe PubMed Central

Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer.

Journal for immunotherapy of cancer
2020-12-01 | Journal article | Author
Contributors: D.P. Hurkmans; Elizabeth Verdegaal; Sabrina Hogan (Schindler); de Wijn R; Hovestad L; van den Heuvel DMA; Ruijtenbeek R; Welters MJP; van Brakel M; Basak EA et al.
Source: Self-asserted source
Sabrina Hogan (Schindler)

Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state

Nature Medicine
2020-10-19 | Journal article
Part of ISSN: 1078-8956
Part of ISSN: 1546-170X
Source: Self-asserted source
Sabrina Hogan (Schindler)

Radiomics, tumor volume and blood biomarkers for early prediction of pseudoprogression in metastatic melanoma patients treated with immune checkpoint inhibition

Clinical Cancer Research
2020-04-06 | Journal article
Part of ISSN: 1078-0432
Part of ISSN: 1557-3265
Source: Self-asserted source
Sabrina Hogan (Schindler)

Genetic and Environmental Determinants of Immune Response to Cutaneous Melanoma

2019-02-17 | Journal article
Part of ISSN: 0008-5472
Part of ISSN: 1538-7445
Source: Self-asserted source
Sabrina Hogan (Schindler)

Melanoma Immunotherapy: Next-Generation Biomarkers.

Frontiers in Oncology
2018 | Journal article
Contributors: Hogan SA; Levesque MP; Cheng PF
Source: Self-asserted source
Sabrina Hogan (Schindler) via Europe PubMed Central

Peripheral blood TCR repertoire profiling may facilitate patient stratification for immunotherapy against melanoma.

Cancer immunology research
2018-11 | Journal article
Contributors: Hogan SA; Courtier A; Cheng PF; Jaberg-Bentele NF; Goldinger SM; Manuel M; Perez S; Plantier N; Mouret JF; Nguyen-Kim TDL et al.
Source: Self-asserted source
Sabrina Hogan (Schindler) via Europe PubMed Central

High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy.

Nature medicine
2018-01 | Journal article
Contributors: Krieg C; Nowicka M; Guglietta S; Schindler S; Hartmann FJ; Weber LM; Dummer R; Robinson MD; Levesque MP; Becher B
Source: Self-asserted source
Sabrina Hogan (Schindler) via Europe PubMed Central

MEK inhibition and immune responses in advanced melanoma.

Oncoimmunology
2017 | Journal article
Source: Self-asserted source
Sabrina Hogan (Schindler) via Europe PubMed Central

The safety of anti PD-1 therapeutics for the treatment of melanoma.

Expert opinion on drug safety
2017-01 | Journal article
Source: Self-asserted source
Sabrina Hogan (Schindler) via Europe PubMed Central